PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
However, the UK National Screening Committee (UKNSC) has announced its draft decision to advise the government against ...
Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.
The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which ...
A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...